Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy
Frank Besag, Michael J. Vasey
Pediatric Drugs (2021) Vol. 23, Iss. 3, pp. 253-286
Closed Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies
Adam Strzelczyk, Susanne Schubert‐Bast
CNS Drugs (2022) Vol. 36, Iss. 10, pp. 1079-1111
Open Access | Times Cited: 95
Fenfluramine: a plethora of mechanisms?
Jo Sourbron, Lieven Lagae
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 28
Neurophysiological findings in Attention Deficit Hyperactivity Disorder, a Pandora’s box with therapeutic implications
Montserrat Gerez-Malo, Armando Tello, Maria Jimena Martin-Salas, et al.
Exploration of Neuroprotective Therapy (2025) Vol. 5
Open Access | Times Cited: 1
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open‐label extension study
Kelly G. Knupp, Ingrid E. Scheffer, Berten Ceulemans, et al.
Epilepsia (2022) Vol. 64, Iss. 1, pp. 139-151
Open Access | Times Cited: 32
Molecular mechanisms of topiramate and its clinical value in epilepsy
Yun-Fei Bai, Chang Zeng, Miaomiao Jia, et al.
Seizure (2022) Vol. 98, pp. 51-56
Open Access | Times Cited: 31
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy
Fabio Perversi, Cinzia Costa, Angelo Labate, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 19
Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopment
Kim I. Bishop, Peter Κ. Isquith, Gérard A. Gioia, et al.
Epilepsy & Behavior (2022) Vol. 138, pp. 108994-108994
Closed Access | Times Cited: 25
Practical considerations for the use of fenfluramine to manage patients with Dravet syndrome or Lennox–Gastaut syndrome in clinical practice
Elaine Wirrell, Lieven Lagae, Ingrid E. Scheffer, et al.
Epilepsia Open (2024) Vol. 9, Iss. 5, pp. 1643-1657
Open Access | Times Cited: 6
IQ changes after pediatric epilepsy surgery: a systematic review and meta-analysis
Tristan Schmidlechner, Malin Zaddach, Florian Heinen, et al.
Journal of Neurology (2023) Vol. 271, Iss. 1, pp. 177-187
Open Access | Times Cited: 12
Zonisamide
Barry E. Gidal, Trevor Resnick, Michael C. Smith, et al.
Neurology Clinical Practice (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Behavioral, neurodevelopmental profile, and epilepsy trajectory in two series of SLC6A1-NDD: a retrospective study with comprehensive assessment, and a participatory database study
Sarah Baer, Mathieu Rebert, Pauline Burger, et al.
European Journal of Paediatric Neurology (2025) Vol. 54, pp. 121-129
Closed Access
Long‐term safety and effectiveness of fenfluramine in children and adults with Dravet syndrome
Ingrid E. Scheffer, Rima Nabbout, Lieven Lagae, et al.
Epilepsia (2025)
Open Access
Differentiation with electroencephalography microstate in temporal lobe epilepsy with and without cognitive decline
Luxian Lv, Nan Lin, Weifang Gao, et al.
Epilepsy & Behavior (2025) Vol. 166, pp. 110365-110365
Open Access
Comparing levetiracetam and zonisamide effects on rivastigmine anti-Alzheimer’s activity in aluminum chloride-induced Alzheimer’s-like disease in rats: Impact on α7 nicotinic acetylcholine receptors and amyloid β
Raafat A. Abdel-Aal, Fatma Y. Meligy, Nashwa Maghraby, et al.
Brain Research (2025), pp. 149573-149573
Closed Access
The effect of anti-seizure medications on Alzheimer's disease (AD) risk and AD-related symptoms: A scoping review
Jonathan Williams, Yiqi Zhu, Ramkrishna K. Singh, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Gaze behavior in infancy associates with developmental outcome at the age of two years in early-onset epilepsies
Henna Jonsson, Sofie de Sena, Tarja Linnankivi, et al.
Epilepsy & Behavior (2025) Vol. 167, pp. 110397-110397
Open Access
Treatment modifications of antiseizure medications in children due to adverse drug reactions: The parents’ perspective
Esther Meise, Thilo Bertsche, Sarah Jeschke, et al.
Epilepsy Research (2025), pp. 107548-107548
Open Access
Injury, child and family/contextual factors predict neurodevelopment outcomes after abusive head trauma
Amy K. Connery, William A. Anastasiadis, Daniel M. Lindberg, et al.
Child Abuse & Neglect (2025) Vol. 164, pp. 107438-107438
Closed Access
Research Advances in Subclinical Discharges in Children
燕燕 穆
Advances in Clinical Medicine (2025) Vol. 15, Iss. 05, pp. 214-220
Closed Access
Research Progress on the Effectiveness and Safety of Lacosamide in the Treatment of Pediatric Epilepsy
泰麟 刘
Advances in Clinical Medicine (2025) Vol. 15, Iss. 05, pp. 919-930
Closed Access
Epilepsy surgery in the first six months of life: A systematic review and meta-analysis
Konstantin L. Makridis, Deniz A. Atalay, Ulrich‐Wilhelm Thomale, et al.
Seizure (2022) Vol. 96, pp. 109-117
Open Access | Times Cited: 16
Optimization of Therapy in Patients with Epilepsy and Psychiatric Comorbidities: Key Points
Francesco Pisani, Laura Rosa Pisani, María Antonietta Barbieri, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 8, pp. 1755-1766
Open Access | Times Cited: 15
Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence
Francesca Bosco, Lorenza Guarnieri, Vincenzo Rania, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12639-12639
Open Access | Times Cited: 9
Cognitive effect of antiseizure medications in medial temporal lobe epilepsy
Cedric Dusanter, Marion Houot, Marie Méré, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 12, pp. 3692-3702
Open Access | Times Cited: 9
Long‐term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: An open‐label, follow‐up trial
Lieven Lagae, Kerstin Alexandra Klotz, András Fogarasi, et al.
Epilepsia (2023) Vol. 64, Iss. 11, pp. 2934-2946
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top